In MASLD, damage to hepatocytes and lipotoxicity provoke an immune reaction that releases pro-inflammatory cytokines such as CXCL9, CXCL10, VCAM-1, IL-6, TNF-α, IL-1β, and IL-17A (37, 38). This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.